Torii

Relearning launch: Four key dynamics for pharma launches in 2019

Japan is recalibrating its traditional national quantitative approach to care decisions with a new regional approach to qualitative health and quality-of-life targets.

Ashfield joins forces with Argon Global Healthcare Network

Doug Burcin, President, Ashfield Healthcare Communications. “We have a well-established presence in the UK, Germany, Japan and US for delivering our solutions at the intersection of science, data and creativity

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

inflammation test for managing asthma, across key markets such as the United States, China, and Japan, as well as the rest of the world.

China first market to approve AZ’s kidney drug roxadustat

AZ and FibroGen have rights to roxadustat in the US, China and other world markets, while Astellas Pharma will sell the drug in Europe and Japan.

Takeda secures investor backing for £46bn Shire takeover

After a gruelling two and a half hour meeting held in Osaka, Japan, almost 90% of shareholders agreed to the takeover, but the decision was met with some resistance. ... Weber is adamant that Shire will help Takeda grow outside Japan, swelling the

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]